4
Changes in Ownership
Lineage Cell Therapeutics, Inc. Filed Acc 0001493152-23-004898
President and CEO gave up 12,744 shares (to pay taxes)
- President and CEO acquired 31,249 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Culley Brian M President and CEO | 2023-02-11 | Option exercise | +31,249 | 139,143 | D: show line 1 in the form | ||
| Culley Brian M President and CEO | 2023-02-11 | Shares withheld for taxes | −12,744 | $1.35 | $17,204 | 126,399 | D: show line 2 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Culley Brian M President and CEO | 2023-02-11 | Option exercise · Restricted Stock Units | −31,249 | 93,748 | D: show line 3 in the form |
Loading xslF345X03/ownership.xml…